secwatch.observer — SEC 8-K summary
======================================

Issuer:     CURIS INC (CRIS)
CIK:        0001108205
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001108205-24-000047
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.03, 5.03, 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Curis cuts workforce ~30%, focuses on combo studies; cash runway into 2025
--------------------------------------------------------------------------

- Board approved ~30% workforce reduction as monotherapy trials near completion.
- Company focusing on combination studies in CNS lymphoma and front-line AML.
- Expects no significant 2024 cost impact; cost reductions anticipated in 2025.
- Stockholders approved increasing authorized common shares to 34,171,875.
- Stockholders approved additional 942,100 shares for 2010 Stock Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1108205/000110820524000047/0001108205-24-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1108205/000110820524000047/cris-20240521.htm
  HTML page:      https://secwatch.observer/filing/0001108205-24-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer